Status:
UNKNOWN
Analysis With Clusters of QUAntitative Tomodensitometric Vascular, bronchIal and Parenchymal Pulmonary Parameters for COPD Patients
Lead Sponsor:
University Hospital, Bordeaux
Collaborating Sponsors:
Transitionnal Research International Laboratory
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
40+ years
Brief Summary
Chronic obstructive pulmonary disease (COPD) is caused by tobacco consumption. The goal is to characterize on clinical and radiological data, using computed tomography, this illness in order to improv...
Detailed Description
Chronic obstructive pulmonary disease (COPD) is characterized by emphysematous destruction of pulmonary parenchyma, airway obstruction that participate in chronic temporary obstruction of airways. COP...
Eligibility Criteria
Inclusion
- Age ≥ 40 years
- Inhalated toxic exposure:
- Tobacco exposure (present or past, over 10 pack years)
- And/or professional exposure to a toxic
- Obstructive syndrome with a FEV1/FVC ≤ 0.7 after inhalation of a bronchodilatator and measured at stable state (without exacerbation)
- Computed tomography performed without injection contrast during common care
Exclusion
- Patients with an exacerbation within 6 weeks before computed tomography
- Artefacts movements on computed tomography incompatible with quantitative analyse
- Broncho-pulmonary cancer (old or present)
- History of pulmonary surgery
- No follow-up for 1 year after scan
- Opposition of the patient to the use of his data (clinical, functional and imaging).
Key Trial Info
Start Date :
December 20 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT03337854
Start Date
December 20 2017
End Date
December 1 2018
Last Update
November 28 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de Bordeaux
Bordeaux, France, 33000